Oxurion announces a reduction in Atlas Special Opportunities II LLC's stake

Leuven, Belgium – Oxurion NV has announced that it has received a transparency notification in accordance with Belgian law. On May 22, 2026, Atlas Special Opportunities II LLC reported holding 4,320,175 shares out of 88,691,312 outstanding shares, thus falling below the 5% threshold following a sale of voting rights.

This development impacts the capital structure of Oxurion, a company specializing in the European pharmaceutical sector, with a strategy of investing in promising subcontractors. Oxurion's headquarters are located in Leuven, Belgium.

The announcement underlines the nature of forward-looking statements, which are subject to risks and uncertainties. The company highlights these elements in its annual report.